Left ventricular assist devices (LVAD) are increasingly used for management of heart failure;
infection remains a frequent complication. Phage therapy has been successful in a variety of …

A double‐stranded RNA (dsRNA) phage phiYY is able to kill a pyomelanin‐producing
Pseudomonas aeruginosa strain, which was isolated from a 40‐year‐old man with interstitial …

Phage-antibiotic synergy (PAS) has been extensively explored over the past decade, with
the aim of developing more effective treatments against multidrug-resistant organisms …

Pseudomonas aeruginosa-associated infective endocarditis represents difficult-to-treat,
deep-seated infections. Phage-antibiotic combinations have shown to eradicate multi-drug …

Despite numerous advances in personalized phage therapy, smooth logistics are
challenging, particularly for multidrug-resistant Gram-negative bacterial infections requiring …

Stenotrophomonas maltophilia is an opportunistic pathogen and frequent cause of serious
nosocomial infections. Patient populations at greatest risk for these infections include the …

Bacteriophages, bacterial viruses, are now being re-highlighted as one of the promising
alternative antimicrobial agents to control bacterial pathogens in various fields, including the …

Methicillin-resistant Staphylococcus aureus (MRSA) causes biofilm-related medical device
infections. Phage-antibiotic combinations offer potential therapy due to proven in vitro …

Phage therapy is one alternative to cure infections caused by antibiotic resistant bacteria.
Due to the narrow host range of phages, hundreds to thousands of phages are required to …

Bacteriophage (phage) therapy is being explored as a possible response to the
antimicrobial resistance public health emergency. Administering a mixture of different phage …